Fig. 3: SGK196 inhibits the migration and invasion of BLBC cells.
From: N-glycosylated SGK196 suppresses the metastasis of basal-like breast cancer cells
a MDA-MB-231 and BT-549 cells were infected with control shRNA and two different SGK196 shRNAs. After antibiotic selection, knockdown of SGK196 was validated by Western blotting analysis. b MDA-MB-231 and BT-549 cells stably expressing HA-SGK196 were validated by western blotting analysis. c–f The resultant stable cell lines with SGK196 knockdown and overexpression were subjected to migration assays (c, d) and invasion assays (e, f). The data are presented as the mean ± S.D, **p < 0.01.
